What is the recommended dosing of Ativan (lorazepam) for status epilepticus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam Dosing for Status Epilepticus

For status epilepticus, the recommended dose of lorazepam is 0.05-0.10 mg/kg IV (maximum: 4 mg per dose), which may be repeated every 10-15 minutes if needed for continued seizures. 1

Adult Dosing

  • Initial dose: 4 mg IV given slowly (2 mg/min) for patients 18 years and older 2
  • If seizures continue or recur after 10-15 minutes observation period, an additional 4 mg IV dose may be administered 2
  • Success rate of approximately 65% for initial control of status epilepticus 3

Pediatric Dosing

  • 0.05-0.10 mg/kg IV (maximum: 4 mg per dose) 1
  • May repeat dose every 10-15 minutes if needed for continued seizures 1
  • Safety in pediatric patients has not been established according to FDA labeling 2

Administration Considerations

  • Administer IV slowly over 2-3 minutes to avoid respiratory depression 1
  • Equipment to maintain a patent airway MUST be immediately available prior to administration 2
  • Continuous monitoring of vital signs, especially respiratory status, is essential 2

Efficacy and Comparative Data

  • Lorazepam is more effective than phenytoin as initial treatment for overt generalized convulsive status epilepticus (64.9% vs 43.6% success rate) 4
  • Equally effective as phenobarbital (58.2%) and diazepam plus phenytoin (55.8%) but easier to use 4
  • More effective for generalized tonic-clonic status epilepticus than for partial status epilepticus with altered responsiveness 5
  • Comparable efficacy to levetiracetam (76.3% for LEV vs 75.6% for lorazepam) in one randomized study 6

Potential Adverse Effects

  • Respiratory depression (most significant risk) 1, 2
  • Increased risk of apnea when combined with other sedative agents 1
  • Hypotension, especially with rapid administration 6
  • Paradoxical agitation may occur, especially in younger children 1

Treatment Algorithm for Status Epilepticus

  1. First-line treatment: Lorazepam 0.05-0.10 mg/kg IV (max 4 mg) over 2-3 minutes 1, 2

    • If IV access unavailable, consider rectal diazepam or nasal/buccal midazolam 7
  2. If seizures persist after 10-15 minutes:

    • Repeat lorazepam dose (same as initial) 2
    • OR proceed to second-line agent
  3. Second-line options if status epilepticus is refractory to benzodiazepines:

    • Phenytoin/Fosphenytoin: 18-20 mg/kg IV (56% success rate) 3
    • Valproate: 20-30 mg/kg IV (88% success rate) 3
    • Levetiracetam: 30-50 mg/kg IV (44-73% success rate) 3
    • Phenobarbital: 10-20 mg/kg IV (58% success rate) 3
  4. For refractory status epilepticus:

    • Consider continuous IV midazolam or propofol 7
    • EEG monitoring is recommended 3

Important Precautions

  • Flumazenil may reverse life-threatening respiratory depression but will also counteract anticonvulsant effects and may precipitate recurrence of seizures 1
  • Intramuscular route is not preferred for status epilepticus as therapeutic levels may not be reached as quickly as with IV administration 2
  • Patients should be observed continuously for recurrence of seizures after initial control 2
  • Treatment of status epilepticus requires more than just anticonvulsant administration—it involves observation and management of all parameters critical to maintaining vital functions 2

Remember that status epilepticus is a medical emergency requiring rapid intervention to minimize neural damage. The goal is to terminate seizures within 10 minutes to reduce the risk of permanent neurological impairment 8.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Seizure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of status epilepticus with lorazepam.

Archives of neurology, 1984

Research

Treatment of Convulsive and Nonconvulsive Status Epilepticus.

Current treatment options in neurology, 2005

Research

Management of status epilepticus.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.